Acquisition Channel Solara's direct-to-patient network surrounds Pal Med's insulin pumps and diabetic testing supplies business, creating a ready-made path to expand distribution and co-market devices across the combined customer base.

Diabetes Device Channel Pal Med's core focus on insulin pumps and diabetic testing supplies signals a strong entry point for partnerships with device manufacturers and distributors seeking increased reach in home diabetes management.

Geographic Synergy With NY presence and SC acquisition, there is potential to harmonize cross-regional DME distribution, exploring partnerships with national players for expanded coverage.

Digital Readiness Limited IT footprint (WordPress/PHP) presents both a risk and an opportunity to modernize patient-facing ordering, telehealth, and secure data exchange, enabling smoother channel partnerships.

Growth Potential Small-scale revenue with room to grow through expanded product bundles, procurement efficiency, and leveraging Solara's network for scalable sales into clinics and direct-to-patient channels.